Rebecca Lehmkuhl
Family · Saint Cloud, MNNPI 1609595107
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 64.3% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2023 at $4,197 and has fallen 98.4% since, to $66 in 2025. Among family clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $77.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$5K
- Medtronic$3K
What the payments were for
- Travel & lodging$3,67048%
- Food & beverage$3,69549%
- Education$2213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 69 | $4,880 |
| Medtronic | 29 | $2,705 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,585 in reported general payments places this provider in the 95th percentile of 1,121 family providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 41 | $39,580 |
| Metoprolol Succinate | 113 | $2,324 |
| ClopidogrelClopidogrel Bisulfate | 49 | $642 |
| Atorvastatin Calcium | 40 | $418 |
| Amlodipine Besylate | 40 | $369 |
| Losartan Potassium | 41 | $320 |
| Carvedilol | 27 | $312 |
| Lisinopril | 20 | $291 |
| Furosemide | 53 | $256 |
| Warfarin Sodium | 20 | $246 |
| Metoprolol Tartrate | 12 | $140 |
| Amoxicillin | 80 | $77 |
Paid to pharmacies, not to this prescriber.
Other family in Saint Cloud
- Erin CarlsenSaint Cloud$4K
- Donna HarrisSaint Cloud$3K
- Amanda ScofieldSaint Cloud$3K
- Erin HewittMinnetonka$172K
- Julia GourdeMinneapolis$65K
- Robin DontaMinneapolis$60K
- Kristin WeberMinneapolis$35K
- Crista WenischBurnsville$30K
- Kathleen FredellMinneapolis$28K
- Christina RichardsonNorthfield$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.